Stueland Katherine

CHIEF EXECUTIVE OFFICER, DirectorGeneDx Holdings Corp. (WGS) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$638K
Net Open-Market Flow
-$638K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2026Option exercise(M)19K$0115K
Jun 16, 2026Sell(S)2K$59.75$128K113K
Jun 16, 2026Sell(S)6K$60.83$361K107K
Jun 16, 2026Sell(S)2K$61.50$149K104K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 16, 2026Option exercise(M)19K$056K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001689575-26-000028) within minutes of acceptance. Every field above traces to the original document. Verify it directly: